298) ked to poor decision-making and increased risk-taking. |
299) which must therefore be deemed an area at risk. |
300) erstanding of the factors involved in HIV risk. |
301) modelled separately for each component of risk. |
302) nificantly associated with bladder cancer risk. |
303) heir use as predictive biomarkers for MFH risk. |
304) mportant in determining long term obesity risk. |
305) -outs may have a different cardiovascular risk. |
306) Poverty represents a considerable health risk. |
307) genotyping information and breast cancer risk. |
308) d/colloid fluid infusion might reduce PRC risk. |
309) group of villages with relatively higher risk. |
310) land has placed neighbouring countries at risk. |
311) friction reaching the skin of patients at risk. |
312) s which could increase the cardiovascular risk. |
313) ed Mantel-Haenszel estimators of relative risk. |
314) o be the underlying basis for sustainable risk assessment and remediation in Europe, |
315) ad limited its application to environment risk assessment and remediation. |
316) bility should be the underlying basis for risk assessment and setting remediation go |
317) Studies on risk assessment displayed two major approa |
318) Environmental risk assessment of sites contaminated with |
319) adopted as part of the contaminated site risk assessment process by the National En |
320) re on four animal models commonly used in risk assessment studies: one bivalve (Myti |
321) Challenges to improve toxicological risk assessment to meet the demands of the |
322) ross other surgical domains and a lack of risk assessment tools. |
323) been used as a key indicator in chemical risk assessment yet poorly quantified risk |
324) uthors as informative for possible future risk assessment. |
325) xicity is a growing trend in nanomaterial risk assessment. |
326) ilability and bioaccessibility for health risk assessment. |
327) oportional increase correlated with GRACE risk score (P < .001). |
328) The authors aimed to develop a diabetes risk score for primary care providers in r |
329) Registry of Acute Coronary Events (GRACE) risk score in patients with ST-segment ele |
330) n-hospital outcomes, independent of GRACE risk score in patients with STEMI. |
|